Suppr超能文献

肥胖症手术患者中有无实体器官移植史的围手术期风险。

Perioperative risks of bariatric surgery among patients with and without history of solid organ transplant.

机构信息

Department of General Surgery, Michigan Medicine, Ann Arbor, Michigan, USA.

University of Miami School of Medicine, Miami, Florida, USA.

出版信息

Am J Transplant. 2020 Sep;20(9):2530-2539. doi: 10.1111/ajt.15883. Epub 2020 May 8.

Abstract

Bariatric surgery is effective among patients with previous transplant in limited case series. However, the perioperative safety of bariatric surgery in this patient population is poorly understood. Therefore, we assessed the safety of bariatric surgery among previous-transplant patients using a database that captures >92% of all US bariatric procedures. All primary, laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass procedures between 2017 and 2018 were identified from the MBSAQIP dataset. Patients with previous transplant (n = 610) were compared with patients without previous transplant (n = 321 447). Primary outcomes were 30 day readmissions, surgical complications, medical complications, and death. Multivariable logistic regression with predictive margins was used to compare outcomes. Previous transplant patients experienced higher incidence of readmissions (8.0% vs 3.5%), surgical complications (5.0% vs 2.7%), and medical complications (4.3% vs 1.5%). There was no difference in incidence of death (0.2% vs 0.1%). Among individual complications, there no statistical differences in intraabdominal leak, unplanned reoperation, myocardial infarction, or infectious complications. Baseline estimated glomerular filtration rate was found to be a strong moderator of primary outcomes, with the highest risk of complications occurring at the lowest baseline estimated glomerular filtration rate. Given the many long-term benefits of bariatric surgery among patients with previous transplant, our findings should not preclude this patient population from operative consideration.

摘要

在有限的病例系列中,减重手术对既往移植患者有效。然而,该患者人群中减重手术的围手术期安全性知之甚少。因此,我们使用一个数据库评估了既往移植患者接受减重手术的安全性,该数据库涵盖了超过 92%的美国减重手术。从 MBSAQIP 数据集中确定了 2017 年至 2018 年间所有原发性、腹腔镜袖状胃切除术和 Roux-en-Y 胃旁路手术。将既往移植(n=610)的患者与无既往移植(n=321447)的患者进行比较。主要结果是 30 天再入院、手术并发症、医疗并发症和死亡。使用预测边际的多变量逻辑回归比较结果。既往移植患者的再入院率(8.0%比 3.5%)、手术并发症发生率(5.0%比 2.7%)和医疗并发症发生率(4.3%比 1.5%)更高。死亡率无差异(0.2%比 0.1%)。在个别并发症中,并未发现腹腔内漏、非计划再次手术、心肌梗死或感染性并发症存在统计学差异。估计肾小球滤过率是主要结局的一个重要调节因素,估计肾小球滤过率最低的患者发生并发症的风险最高。鉴于既往移植患者接受减重手术有许多长期益处,我们的发现不应排除该患者人群进行手术考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2149/7838764/fd540696401b/nihms-1655747-f0001.jpg

相似文献

引用本文的文献

8
Outcomes of Bariatric Surgery After Solid Organ Transplantation.实体器官移植后减重手术的结果。
Obes Surg. 2020 Dec;30(12):4899-4904. doi: 10.1007/s11695-020-05013-1. Epub 2020 Sep 30.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验